Latest news
Targeted Therapy Resistance in NSCLC: Critical Next Steps - OncodailyOncodaily · Sun, 09 Aug 2026 15:22:32 GMTCalreticulin-targeted L-asparaginase–flagellin conjugate boosts Salmonella’s antitumor effectiveness - Bioengineer.orgBioengineer.org · Sun, 09 Aug 2026 03:59:41 GMTCholangiocarcinoma Market - Future Market InsightsFuture Market Insights · Sat, 08 Aug 2026 13:55:46 GMTNewer cancer therapies improve outcomes in cancer-related CAD - Cold Agglutinin Disease NewsCold Agglutinin Disease News · Sat, 08 Aug 2026 06:36:22 GMTHER2 Mutations in NSCLC: Critical Risks of Outdated Terms - OncodailyOncodaily · Fri, 07 Aug 2026 16:43:17 GMTTreatment Strategies Following Progression in EGFR-Mutant NSCLC - OncLiveOncLive · Fri, 07 Aug 2026 01:41:15 GMTRadiopharmaceutical May Benefit Patients with Metastatic Prostate Cancer Sooner - WCM NewsroomWCM Newsroom · Thu, 06 Aug 2026 22:47:14 GMTThe Impact of Bispecifics in Community Oncology Settings - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 19:59:43 GMT